Junjiang Fu

48PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersMedical infection agents (incl. prions)Flight dynamicsMolecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (48)

|Apr 06, 2026
Sex determining region Y box protein 2 (SOX2) expression, alteration, regulation and its diagnostics, prognostics and therapeutics in lung cancer.

Xia Jiang, Meiling Zheng, Lianmei Zhang

|Oct 13, 2025
Molecular biology research progress in post-mortem interval (PMI) estimation in forensic medicine.

Ting He, Binghui Song, Junjiang Fu

|Jul 23, 2025
Novel Thymoquinone Derivative TQFL28 Inhibits Triple-Negative Breast Cancer (TNBC) Invasiveness In Vitro and In Vivo.

Jiayue He, Hui Zou, Chunli Wei

|Jul 10, 2025
Correction: Impact of BSG/CD147 gene expression on diagnostic, prognostic and therapeutic strategies towards malignant cancers and possible susceptibility to SARS-CoV-2.

Jiewen Fu, Binghui Song, Jiaman Du

|Feb 26, 2025
TQFL19, a Novel Derivative of Thymoquinone (TQ), Plays an Essential Role by Inhibiting Cell Growth, Metastasis, and Invasion in Triple-Negative Breast Cancer.

Ali El-Far, Xiaoyan Liu, Ting Xiao

|Feb 13, 2025
Exploring the Post Mortem Interval (PMI) Estimation Model by circRNA circRnf169 in Mouse Liver Tissue.

Jiewen Fu, Binghui Song, Jie Qian

Pageof 8

Frequent Collaborators

9 joint publications

Jingliang Cheng

6 joint publications

Jiewen Fu

5 joint publications

Md Asaduzzaman Khan

3 joint publications

Xiaotao Li